Results 241 to 250 of about 3,437,924 (390)
Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.Abstract Aims
The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś +12 morewiley +1 more sourceArtificial intelligence-enhanced electrocardiography and sudden death risk factors in cardiac arrest survivors diagnosed with hypertrophic cardiomyopathy. [PDF]
Heart Rhythm O2Swain WH, Giudicessi JR, Geske JB, Newman DB, Bos JM, Karim S, Noseworthy PA, Attia ZI, Friedman PA, Arruda-Olson AM, Ackerman MJ, Ommen SR, Siontis KC. +12 moreeuropepmc +1 more sourceLong‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis
ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.Abstract Aims
Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil +12 morewiley +1 more sourceCurrent causes of sudden death in large populations: differences between resuscitated patients and autopsied cases. [PDF]
Eur Heart J OpenMarimpouy N, Guilbeau-Frugier C, Ramirez A, Beneyto M, Delmas C, Biendel C, Cherbi M, Foltran D, Mondoly P, Timnou Bekouti J, Ferrières J, Telmon N, Bongard V, Delasnerie H, Rollin A, Maury P. +15 moreeuropepmc +1 more source[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].
Kardiologia polska, 2015 S. Priori, Carina Blomström-Lundqvist, Andrea Mazzanti, Nico Blom, Martin Borggrefe, John Camm, P. M. Elliott, Donna Fitzsimons, Róbert Hatala, G. Hindricks, P. Kirchhof, K. Kjeldsen, K. Kuck, A. Hernández–Madrid, Nikolaos Nikolaou, T. Norekvål, Christian Spaulding, Dirk J Van Veldhuisen +17 moresemanticscholar +1 more sourceEffects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life
ESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims
Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.Jia Liao, Yang Chen, Zhiyu Ling, Helmut Pürerfellner, Martin Martinek, Michael Derndorfer, Johannes Niel, Ramin Ebrahimi, Matthias Heukäufer, Sarah Janschel, Davide Di Vece, Klaus Empen, Astrid Hummel, Bishwas Chamling, Piotr Futyma, Fahim Ebrahimi, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Alexandra Schratter, Willem‐Jan Acou, Philipp Sommer, Boris Schmidt, Julian K. R. Chun, Christian Meyer, Marcus Dörr, Christian Templin, Shaojie Chen +27 morewiley +1 more source